tristearin has been researched along with Experimental Mammary Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bendayan, R; Rauth, AM; Wong, HL; Wu, XY | 1 |
1 other study(ies) available for tristearin and Experimental Mammary Neoplasms
Article | Year |
---|---|
In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
Topics: Alkanes; Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Chemistry, Pharmaceutical; Delayed-Action Preparations; Dose-Response Relationship, Drug; Doxorubicin; Drug Carriers; Drug Compounding; Epoxy Compounds; Female; Injections, Intralesional; Lipids; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nanoparticles; Polymers; Stearic Acids; Technology, Pharmaceutical; Time Factors; Triglycerides | 2007 |